Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07169760 · ClinicalTrials.gov registry record · Phase 4
R61/33 - VR Study Phase 4
A Phase 4 study of Attention Deficit Hyperactivity Disorder, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 252
- Enrollment target
- 2
- Study locations
NCT07169760 is a Phase 4 study of Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 252 participants, above the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (24% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT07169760, a Phase 4 study of Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 252 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.
Conditions Studied
Interventions
- BEHAVIORAL Meta Quest 3 VR Headset with noise cancelling headphones
Study Locations (2)
Louisiana
- Louisiana State University - Baton Rouge
New Jersey
- Rutgers University - New Brunswick - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2030-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07169760
The ClinicalTrials.gov registry entry for NCT07169760 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (24% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Meta Quest 3 VR Headset with noise cancelling headphones is the first listed.
NCT07169760 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Louisiana, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07169760 about?
NCT07169760 is a clinical study titled "R61/33 - VR Study Phase 4". The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the imp...
What is the current status of trial NCT07169760?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 252 participants. The study started on 2025-09-09. Estimated completion is 2030-12.
What conditions does trial NCT07169760 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT07169760?
The interventions under investigation include: Meta Quest 3 VR Headset with noise cancelling headphones (BEHAVIORAL).
Who is sponsoring clinical trial NCT07169760?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07169760 being conducted?
This trial has 2 study locations across Louisiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
RECRUITING · Phase 4
-
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
RECRUITING · Phase 4
-
Stimulant Effects on Disruptive Behavior
RECRUITING · Phase 4
-
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate
COMPLETED · Phase 4
-
A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.